Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Virtual Event

Sep 28, 2020 2:00 PM - Sep 30, 2020 6:00 PM

(Central Europe Standard Time)

4051 Basel, Switzerland

Regulatory Science Forum

Session 3: Nanosimilars

Session Chair(s)

Jon S De Vlieger, PhD

Jon S De Vlieger, PhD

Coordinator NBCD Working Group and Director Business Development

Lygature, Netherlands

Session 3: Nanosimilars

Speaker(s)

Susanne  Bremer-Hoffmann

Identification of regulatory needs for nanomedicines

Susanne Bremer-Hoffmann

European Commission, Italy

Joint Research Centre (JRC)

Kevin  Klein, PhD, MSc

The EU regulatory landscape of non-biological complex drugs (NBCDs) follow-on products: Observations and recommendations

Kevin Klein, PhD, MSc

Lygature, Netherlands

Program Manager

Falk  Ehmann, MD, PhD, MS

EMA’s approach to the Evaluation of Medicines containing Nanotechnology

Falk Ehmann, MD, PhD, MS

Regulatory Science and Innovation Task Force, European Medicines Agency, Netherlands

Head of Innovation and Development Accelerator – ad interim

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.